Study #2023-0492
Effect of Olanzapine on opioid craving and misuse among patients receiving opioids for cancer-related pain: a pilot doubleblind, randomized control trial.
MD Anderson Study Status
Enrolling
Treatment Agent
Olanzapine, Placebo
Description
To learn about the effectiveness of taking the antipsychotic medication olanzapine to help lower opioid craving.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Misuse, Opioid
Study phase:
Phase III
Physician name:
Joseph Arthur
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-844-580-2777
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.